Wells Fargo analyst Gabe Hajde raised the firm's price target on AptarGroup to $145 from $144 and keeps an Overweight rating on the shares. While the firm acknowledges the Middle East conflict could drive a temporary slow-down for some of its semi-discretionary beauty and personal care products, Wells argues that an impending Pharma inflection, a best-in-class balance sheet, and favorable shareholder returns support an Overweight rating.
